Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy

被引:58
作者
Okuda, T [1 ]
Takeda, K
Fujita, Y
Nishimura, M
Yagyu, S
Yoshida, M
Akira, S
Downing, JR
Abe, T
机构
[1] Kyoto Prefectural Univ Med, Dept Hyg, Kamigyo Ku, Kyoto 6028566, Japan
[2] Kyoto Prefectural Univ Med, Dept Internal Med, Kamigyo Ku, Kyoto 6028566, Japan
[3] Kyoto Prefectural Univ Med, Dept Surg, Kamigyo Ku, Kyoto 6028566, Japan
[4] Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo, Japan
[5] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA
关键词
D O I
10.1128/MCB.20.1.319-328.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AML1 is one of the most frequently mutated genes associated with human acute leukemia and encodes the DNA-binding subunit of the heterodimering transcriptional factor complex, core-binding factor (CBF) (or polyoma enhancer binding protein 2 [PEBP2]). A null mutation in either AML1 or its dimerizing partner, CBF beta, results in embryonic lethality secondary to a complete block in fetal liver hematopoiesis, indicating an essential role of this transcription complex in the development of definitive hematopoiesis. The hematopoietic phenotype that results from the loss of AML1 can be replicated in vitro with a two-step culture system of murine embryonic stem (ES) cells. Using this experimental system, we now demonstrate that this hematopoietic defect can be rescued by expressing the PEBP2 alpha B1 (AML1b) isoform under the endogenous AML1-regulatory sequences through a knock-in (targeted insertion) approach. Moreover, we demonstrate that the rescued AML1(-/-) ES cell clones contribute to lymphohematopoiesis within the context of chimeric animals. Rescue requires the transcription activation domain of AML1 but does not require the C-terminal VWRPY motif, which is conserved in all AML1 family members and has been shown to interact with the transcriptional corepressor, Groucho/transducin-like Enhancer of split. Taken together, these data provide compelling evidence that the phenotype seen in AML1-deficient mice is due solely to the loss of transcriptionally active AML1.
引用
收藏
页码:319 / 328
页数:10
相关论文
共 56 条
  • [1] BAE SC, 1993, ONCOGENE, V8, P809
  • [2] PEBP2-ALPHA-B/MOUSE AML1 CONSISTS OF MULTIPLE ISOFORMS THAT POSSESS DIFFERENTIAL TRANSACTIVATION POTENTIALS
    BAE, SC
    OGAWA, E
    MARUYAMA, M
    OKA, H
    SATAKE, M
    SHIGESADA, K
    JENKINS, NA
    GILBERT, DJ
    COPELAND, NG
    ITO, Y
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) : 3242 - 3252
  • [3] LEUKEMIA DROSOPHILA HOMOLOGY
    DAGA, A
    TIGHE, JE
    CALABI, F
    [J]. NATURE, 1992, 356 (6369) : 484 - 484
  • [4] The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: Biology and clinical significance
    Downing, JR
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) : 296 - 308
  • [5] MOUSE EMBRYONIC HEMATOPOIESIS
    DZIERZAK, E
    MEDVINSKY, A
    [J]. TRENDS IN GENETICS, 1995, 11 (09) : 359 - 366
  • [6] ERICKSON P, 1992, BLOOD, V80, P1825
  • [7] The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family
    Gamou, T
    Kitamura, E
    Hosoda, F
    Shimizu, K
    Shinohara, K
    Hayashi, Y
    Nagase, T
    Yokoyama, Y
    Ohki, M
    [J]. BLOOD, 1998, 91 (11) : 4028 - 4037
  • [8] Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions
    Ghozi, MC
    Bernstein, Y
    Negreanu, V
    Levanon, D
    Groner, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) : 1935 - 1940
  • [9] FUSION OF PDGF RECEPTOR-BETA TO A NOVEL ETS-LIKE GENE, TEL, IN CHRONIC MYELOMONOCYTIC LEUKEMIA WITH T(512) CHROMOSOMAL TRANSLOCATION
    GOLUB, TR
    BARKER, GF
    LOVETT, M
    GILLILAND, DG
    [J]. CELL, 1994, 77 (02) : 307 - 316
  • [10] TLE, the human homolog of Groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation
    Imai, Y
    Kurokawa, M
    Tanaka, K
    Friedman, AD
    Ogawa, S
    Mitani, K
    Yazaki, Y
    Hirai, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 252 (03) : 582 - 589